Studies have shown that people with high levels of omega-3s are better protected against serious COVID-19 infections.

Published Date: 02 Mar 2023

A study recently published in the American Journal of Clinical Nutrition (AJCN) investigated the role of omega-3 fatty acids, specifically EPA and DHA, and whether they can prevent poor and/or negative weight loss. .

Read Full News

Latest News

Kennedy Allies Petition to Broaden US Vaccine Injury List

An anti-vaccine group aligned with U.S. Health Secretary Robert F. Kennedy Jr. is petitioning him to vastly broaden a federal list to include more than 300 injuries it says...

Kids Confirmed as Top Transmitters of RSV

New modeling data support targeted prevention efforts.

Kent Meningitis Outbreak Triggers Surge in UK Vaccine Demand, Policy Debate

Young people in southeast England and beyond are lining up for the meningitis B vaccine after an outbreak killed two people, sparking supply warnings from pharmacies and...

Parasitic Worms Provide Insights on RSV Prevention

Researchers identify metabolite alternatives to helminth-influenced protection.

Viral Coinfection May Predict Bacteremic Pneumonia

Patients with respiratory viral co-infection may have an increased risk of developing bacteremic Staphylococcus aureus pneumonia and 30-day mortality compared with those without viral co-infection.

UK Says Vaccine Protects Against Strain in Deadly Meningitis Outbreak

Britain's health authorities said on Friday that early laboratory analysis had shown the vaccine being ⁠offered to students should protect against the strain of meningitis...

Todays Updates

Insulin Resistance Detected Early May Guide HS Therapy

Screening for insulin resistance early after the diagnosis of hidradenitis suppurativa shows promise for guiding therapies to improve the disease course.

Dermatomyositis: Targeted Drug Shows Promise vs Placebo

At 52 weeks, the 30-mg daily oral dose of brepocitinib outperformed the 15-mg dose in a study of patients with dermatomyositis resistant to previous treatments.

Melasma: A New Era of Topical Treatment Options Galore

Combination therapies remain key as multiple agents for melasma hit the market.

LAAC an Alternative for NOAC in Lower-Risk AF Patients

CHAMPION-AF finds left atrial appendage closure and anticoagulation therapy for atrial fibrillation about equal but raises doubts about whether the former is a true alternative.

Fibrinolytic Beats Current Standard for Intermediate-Risk PE

For intermediate-risk pulmonary embolism, a low-dose fibrinolysis strategy reduced PE-related events by half with no significant increase in bleeding vs standard therapy.

PCKS9 Inhibitors Seen Driving Down LDL-C in Diabetes

A subgroup analysis of the VESALIUS-CV trial showed evolocumab significantly cut LDL cholesterol and cardiovascular event risk in people with diabetes but no known atherosclerosis.

High Dx Yield Supports Workup for INOCA

Performed with favorable safety, the diagnostic yield for coronary function testing in patients with ischemia but nonobstructive arteries was found to exceed 90%.

Todays Updates

Insulin Resistance Detected Early May Guide HS Therapy

Screening for insulin resistance early after the diagnosis of hidradenitis suppurativa shows promise for guiding therapies to improve the disease course.

Dermatomyositis: Targeted Drug Shows Promise vs Placebo

At 52 weeks, the 30-mg daily oral dose of brepocitinib outperformed the 15-mg dose in a study of patients with dermatomyositis resistant to previous treatments.

Melasma: A New Era of Topical Treatment Options Galore

Combination therapies remain key as multiple agents for melasma hit the market.

LAAC an Alternative for NOAC in Lower-Risk AF Patients

CHAMPION-AF finds left atrial appendage closure and anticoagulation therapy for atrial fibrillation about equal but raises doubts about whether the former is a true alternative.

Fibrinolytic Beats Current Standard for Intermediate-Risk PE

For intermediate-risk pulmonary embolism, a low-dose fibrinolysis strategy reduced PE-related events by half with no significant increase in bleeding vs standard therapy.

PCKS9 Inhibitors Seen Driving Down LDL-C in Diabetes

A subgroup analysis of the VESALIUS-CV trial showed evolocumab significantly cut LDL cholesterol and cardiovascular event risk in people with diabetes but no known atherosclerosis.

High Dx Yield Supports Workup for INOCA

Performed with favorable safety, the diagnostic yield for coronary function testing in patients with ischemia but nonobstructive arteries was found to exceed 90%.

Latest News

An anti-vaccine group aligned with U.S. Health Secretary Robert F. Kennedy Jr. is petitioning him to vastly broaden a federal list to include more than 300 injuries it says...

New modeling data support targeted prevention efforts.

Young people in southeast England and beyond are lining up for the meningitis B vaccine after an outbreak killed two people, sparking supply warnings from pharmacies and...

Researchers identify metabolite alternatives to helminth-influenced protection.

Patients with respiratory viral co-infection may have an increased risk of developing bacteremic Staphylococcus aureus pneumonia and 30-day mortality compared with those without viral co-infection.

Britain's health authorities said on Friday that early laboratory analysis had shown the vaccine being ⁠offered to students should protect against the strain of meningitis...

News All Time

US Insurers and Hospitals Turn to New AI for Age-old Battle Over Charges Vs Payments

Artificial intelligence is being deployed on both sides of the tug-of-war between U.S. healthcare systems that want to be paid more for medical procedures and insurers who...

Viatris Settles lawsuit Over Use Of Woman's 'immortal' Cells to Power Drug Research

Generic drugmaker Viatris has settled a lawsuit brought by the family of Henrietta Lacks, a Maryland woman whose ⁠tissue samples were used without her permission to develop...

RSV Hospitalization Burden Rises With Age and Comorbidities

Respiratory syncytial virus is associated with a greater burden of hospitalizations in older adults and in those with congestive heart failure or chronic obstructive pulmonary disease.

US Vaccine Advisers Drop Plan to Question MRNA COVID Shots, WaPo Reports

A key U.S. federal vaccine advisory panel has dropped a push against COVID mRNA vaccines, ⁠the Washington Post reported on Wednesday, citing two people familiar with the...

No Link Between HPV Vaccination and Infertility

A Cochrane review of 225 studies covering 132 million vaccinated people found, with high certainty, that HPV vaccination does not cause fertility problems, refuting a common myth.

South Carolina Reports One Additional Measles Case, Total Cases Rise to 991

Measles cases in South Carolina rose to 991 on Friday, state health data ⁠showed, an increase of one case since Tuesday as the nation's largest outbreak in ⁠decades shows...

mRNA RSV Vaccine Safe in Transplant Recipients

mRNA-1345 vaccine is safe and well tolerated and elicits measurable antibody and cellular immune responses in recipients with solid organ transplant.

HIV Hits the Nervous System Early

Cerebrospinal fluid samples show signs of inflammation.

Exercise Training Benefits HIV Patients Below the Surface

Genetic analysis shows signs of cellular repair and slower aging.

Dolutegravir Shows Continued Success in Youth With HIV

Dolutegravir reduces viral load in adolescents and children in low- to middle-income nations.

US CDC Deploys Staff to Curb South Carolina's Measles Outbreak

(Refiles to remove extraneous word years from first paragraph)

After FDA Declined Review, EMA Backs 1st Flu-COVID mRNA Vax

The Moderna vaccine will likely be available in Europe long before the US.

Peak Anti-HBs Level May Predict Protection in HIV Infection

Peak anti-hepatitis B surface antibody levels predicted increased viral protection in HIV, a French study shows.

Doravirine Plus Islatravir Matches Standard HIV Therapy

In patients with HIV‑1 infection and virologic suppression, switching to an investigational regimen of doravirine plus islatravir shows efficacy and safety similar to standard ART regimens.

European Guidance Advances Cardiovascular Risk Assessment

The 2025 update integrates new risk estimation tools and shifts acute coronary syndrome management toward earlier intensive lipid-lowering therapy.

Exclusive-US Postpones Third Consecutive Meeting Of Preventive Health Panel

The March meeting of the U.S. advisory panel that determines what cancer screenings and other preventive health measures insurers must cover has been postponed, according to...

Recommended News For You

Early cancer detection during pregnancy and the postpartum period may be aided by breast milk examination.

Risk of a Second Primary Melanoma Similar Regardless of Race/Ethnicity

Hemihedral resection not necessary for neuroendocrine surgery after appendicitis

Men With Prostate Cancer Experience Less Hot Flashes When Using an Affordable Drug.

Specialist Referrals Are Critical for Functional High-Risk Multiple Myeloma

FDA Approves Treosulfan as Part of AML/MDS Conditioning Regimen

Recurrent UTIs impact eGFR in children with vesicoureteral reflux

Recommended Articles For You

Breast Cancer Secrets: AI-Powered Precision Medicine 

Exploring The Science Of Hematopoietic Stem Cell Transplantation: What You Need To Know 

Emerging Chemo-Immunotherapy: New Agents and Mechanisms in Modern Oncology 

Genetic Testing in Cancer Prevention: BRCA Mutations and Lynch Syndrome Unlocked 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

No increased risk of childhood cancer near UK nuclear sites, study finds

2.

It Is Cancer in Kate Middleton.

3.

Belzutifan Combo Could be Second-Line Option in Advanced RCC

4.

Future of Lab-Developed Tests Still Taking Shape

5.

Biomarker panel offers hope for early pancreatic cancer detection

1.

Symptoms and Causes of Phlegmasia Cerulea Dolens: A Comprehensive Guide 

2.

Revolutionizing Cancer Care: The Transformative Role of AI and Data Science in Oncology

3.

New Research Advances in the Treatment of Multiple Myeloma and Plasmacytoma 

4.

Personalized Neoantigen Vaccines and the Promise of a Less Toxic Future in Pediatric Oncology

5.

Precision Oncology: Tailoring Cancer Treatment for the Individual

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Benefits of Treatment with CDK4/6 Inhibitors in HR+/HER2- aBC in Clinical Trials and the Real World

2.

Breaking Down PALOMA-2: How CDK4/6 Inhibitors Redefined Treatment for HR+/HER2- Metastatic Breast Cancer

3.

Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Final Discussion

4.

Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- Further Discussion on A New Perspective

5.

A Conclusive Discussion on CROWN Trial and the Dawn of a New Era in Frontline Management of ALK+ NSCLC

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot